Dr. Zin W. Myint
Claim this profileUniversity of Kentucky/Markey Cancer Center
Studies Cancer
Studies Prostate Cancer
12 reported clinical trials
26 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
2Prostate Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Zin W. Myint is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Radioactive Drug Therapy
for Prostate Cancer
This trial studies how well lutetium Lu 177 dotatate works in treating patients with a specific type of prostate cancer that has spread. The drug targets cancer cells and releases radiation to kill them. Lutetium-177 (Lu-177) PSMA therapy is a targeted treatment for advanced prostate cancer that has shown promising results.
Recruiting1 award Phase 216 criteria
More about Zin W. Myint
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Zin W. Myint has experience with
- Pembrolizumab
- Nivolumab
- Ipilimumab
- Avelumab
- Gemcitabine Hydrochloride
- Abemaciclib
Breakdown of trials Zin W. Myint has run
Cancer
Prostate Cancer
Tumors
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Zin W. Myint specialize in?
Zin W. Myint focuses on Cancer and Prostate Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Zin W. Myint currently recruiting for clinical trials?
Yes, Zin W. Myint is currently recruiting for 7 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Zin W. Myint has studied deeply?
Yes, Zin W. Myint has studied treatments such as Pembrolizumab, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Zin W. Myint?
Apply for one of the trials that Zin W. Myint is conducting.
What is the office address of Zin W. Myint?
The office of Zin W. Myint is located at: University of Kentucky/Markey Cancer Center, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky/Markey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.